ARCHIVES

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

This article is from The Cancer Letter archive.

Vol. 23 No. 40 | October 17, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

New Concept For Prevention Units Goes to DCPC BSC

April 24, 1987

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991